These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2699345

  • 21. Myocardial dysfunction in septic shock: Part II. Role of cytokines and nitric oxide.
    Kumar A, Krieger A, Symeoneides S, Kumar A, Parrillo JE.
    J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):485-511. PubMed ID: 11505357
    [No Abstract] [Full Text] [Related]

  • 22. [Humoral factors in the pathogenesis of shock].
    Tang CS.
    Sheng Li Ke Xue Jin Zhan; 1984 Oct; 15(4):364-70. PubMed ID: 6085777
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The physiopathology of shock.
    Van de Walle J, Lauwers P.
    Med Welt; 1975 Aug 22; 26(33-34):1470-3. PubMed ID: 1177715
    [No Abstract] [Full Text] [Related]

  • 26. [Positive modification of hemodynamics in post cardiac surgery patients by hemofiltration. Improved method for the demonstration of myocardial depressant factor (MDF) in hemofiltrate].
    Coraim F, Pauser G, Stellwag F, Werner T, Ziegler W.
    Anaesthesist; 1985 May 22; 34(5):236-40. PubMed ID: 4025793
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM, Lefer DJ, Levin RJ.
    Adv Shock Res; 1980 May 22; 3():167-74. PubMed ID: 6118024
    [Abstract] [Full Text] [Related]

  • 33. [Effect of administration of a large dose of corticosteroids in hemorrhagic shock].
    Okada K, Kosugi I, Yamaguchi S, Innan H, Kawashima Y.
    Masui; 1974 Nov 22; 23(12):1170-7. PubMed ID: 4477607
    [No Abstract] [Full Text] [Related]

  • 34. N,N',N"-triacetylglucosamine, an inhibitor of lysozyme, prevents myocardial depression in Escherichia coli sepsis in dogs.
    Mink SN, Jacobs H, Duke K, Bose D, Cheng ZQ, Light RB.
    Crit Care Med; 2004 Jan 22; 32(1):184-93. PubMed ID: 14707578
    [Abstract] [Full Text] [Related]

  • 35. Protective actions of nafazatrom in traumatic shock.
    Lefer AM, Messenger M.
    Arzneimittelforschung; 1982 Jan 22; 32(9):1089-91. PubMed ID: 6890831
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Studies on low molecular weight inotropic plasma substances in prolonged hypovolemic traumatic shock.
    Hallström S, Vogl C, Krösl P, Redl H, Schlag G.
    Prog Clin Biol Res; 1987 Jan 22; 236A():591-7. PubMed ID: 3615453
    [No Abstract] [Full Text] [Related]

  • 38. Effect of extracts from ischemic pancreas (myocardial depressant factor?) on platelets.
    Yarom R, Sagher U, Rosen H, Becker Y, More R, Chandler JA.
    Isr J Med Sci; 1982 Jun 22; 18(6):689-94. PubMed ID: 7107206
    [No Abstract] [Full Text] [Related]

  • 39. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE, Lefer AM.
    Circ Shock; 1985 Jun 22; 17(4):263-72. PubMed ID: 3841503
    [Abstract] [Full Text] [Related]

  • 40. Depression of myocardial contractility is not a causative factor for circulatory deterioration in two experimental models of shock in anesthetized dogs.
    Jacinto SM, Jandhyala BS.
    Ann N Y Acad Sci; 1994 Jun 17; 723():345-8. PubMed ID: 8030881
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.